Latest 30 News in the Life Sciences Industry
GlobeNewswire
Nobel-Potential Discovery from VectorBuilder Scientists Reveals Fundamental Mechanisms of Development
21 Apr 2026
GlobeNewswire
ITM to Announce Quality of Life Data from the Phase 3 COMPETE Trial in Patients with Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs) at ASCO 2026
21 Apr 2026
GlobeNewswire
Immatics Announces Four Upcoming Oral Presentations Across Its Clinical Cell Therapy and Bispecific Portfolio at 2026 ASCO Annual Meeting
21 Apr 2026
GlobeNewswire
Dewpoint Therapeutics Reports Preclinical Data on Oral MYC Condensate Modulator at AACR 2026
21 Apr 2026
GlobeNewswire
BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026
21 Apr 2026
GlobeNewswire
Novo Nordisk: Etavopivat is the first in a new class of drugs to meet both co-primary endpoints in the phase 3 HIBISCUS trial, substantially reducing vaso-occlusive crisis events and improving haemoglobin response in sickle cell disease
20 Apr 2026
GlobeNewswire
Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter
20 Apr 2026
PR Newswire Association LLC.
Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows
20 Apr 2026
GlobeNewswire
PRAME-directed Cell Therapy Using Immatics’ TCR Induces Deep and Durable Remission in Pediatric Patient with Advanced Metastatic Nephroblastoma
17 Apr 2026
GlobeNewswire
Beamion LUNG-1 study results for zongertinib in treatment-naïve patients with HER2-mutant advanced NSCLC published in The New England Journal of Medicine
16 Apr 2026
PR Newswire Association LLC.
Prof. Dr. Wilhelm Haverkamp Appointed Chief Medical Officer at SCIRENT
16 Apr 2026
GlobeNewswire
Aicuris Receives FDA Priority Review for Pritelivir NDA and Presents New Phase 3 Data at ESCMID 2026
16 Apr 2026
GlobeNewswire
Boehringer Ingelheim and Zai Lab announce Collaboration on DLL3‑targeting T‑Cell Engager and ADC Combination in Small Cell Lung Cancer and Other Neuroendocrine Carcinomas
15 Apr 2026
PR Newswire Association LLC.
HIKMICRO Strengthens Instrumentation Push with LRG10 Series Radar Level Meter
15 Apr 2026
GlobeNewswire
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
15 Apr 2026
GlobeNewswire
Alira Health and Autoimmune Neurology Alliance (AiNA) Launch AXIS Registry, Advancing Real-World and Patient-Centered Research in Autoimmune Neurology
15 Apr 2026
PR Newswire Association LLC.
triSure NIPT Debuts in Taiwan, Expanding Non-Invasive Prenatal Screening Beyond Aneuploidy
14 Apr 2026
GlobeNewswire
Real-World Evidence and Industry Momentum Builds for iMDx’s Flagship GraftAssure Assay
14 Apr 2026
PR Newswire Association LLC.
10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood
19 Apr 2026
PR Newswire Association LLC.
ESCMID Global: Maternal RSV vaccination cuts infant hospitalisation risk by over 80%, major UKHSA study finds
18 Apr 2026
PR Newswire Association LLC.
Ada Health Patents the Clinical Layer That Makes LLMs Safe for Healthcare
13 Apr 2026
PR Newswire Association LLC.
"In Europe, For Europe": Haier Biomedical Spotlights Full-Scenario Lab Solutions at analytica Munich 2026
10 Apr 2026
PR Newswire Association LLC.
Co-Diagnostics Executives to Participate in European Trade Mission with Utah Governor and WTC Utah
09 Apr 2026
PR Newswire Association LLC.
Largest Clinical Study of XyliMelts® Shows Significant Relief for Dry Mouth While Sleeping
08 Apr 2026
PR Newswire Association LLC.
ZEISS advances connected cataract and refractive workflows with new digital, AI and surgical innovations at ASCRS
02 Apr 2026
Latest News All News
Upcoming Events All Events
- April 2026
- Seattle: Life Science Innovation Northwest 2026
- Leipzig: German Biotech Days
- Shanghai: ChinaBio® Partnering Forum